- Filed
- Apr 24, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 18, 2025 | 35.27M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $63.78M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $62.29M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $204.76M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $549.94M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $2.41B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $2.58B |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $2.79B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $3.01B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $2.6B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $2.79B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $4.57B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $4.71B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 35.83M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $295K |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $8.92M |
| Capex | Q1 2025 · Mar 31, 2024 | $24.95M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $146.56M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $1.37B |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $1.28B |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $2.69 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $2.70 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $162.72M |
| Net Income | Q1 2025 · Mar 31, 2024 | $96.32M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $135.46M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $297.36M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $1.24B |